MA08.01 A Highly Sensitive Next-Generation Sequencing Platform for Detection of NSCLC EGFR T790M Mutation in Urine and Plasma  Heather Wakelee, Vlada.

Slides:



Advertisements
Similar presentations
A Hole in the Heart Journal of Thoracic Oncology
Advertisements

A2-06: Survival differences for non-Bronchioloalveolar Carcinoma (BAC) non-small-cell lung cancer (NSCLC) cases with ipsilateral intrapulmonary metastasis.
Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,
Brain Radionecrosis Treated with Bevacizumab in a Patient with Resected Squamous Cell Carcinoma of the Lung  Jordi Remon, MD, Cécile Le Péchoux, MD, Caroline.
A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and Plasma  Karen L. Reckamp, MD, Vladislava O. Melnikova,
T790M EGFR Mutation Detection in Cerebrospinal Fluid and Response to Osimertinib in a Lung Cancer Patient with Meningeal Carcinomatosis  Hugo Gortais,
Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.
SC17.02 Lung Cancer in China: Challenges and Perspectives
Journal of Thoracic Oncology  Volume 11, Issue 4, Pages (April 2016)
PL03.07: First-line Ceritinib Versus Chemotherapy in Patients with ALK-rearranged (ALK+) NSCLC: A Randomized, Phase 3 Study (ASCEND-4)  Gilberto De Castro,
T790M EGFR Mutation Detection in Cerebrospinal Fluid and Response to Osimertinib in a Lung Cancer Patient with Meningeal Carcinomatosis  Hugo Gortais,
P3.02b-001 Phase 1 Dose Escalation of PF (EGFR-T790M Inhibitor) in Patients with Advanced EGFRm (Del 19 or L858R+/-T790M) NSCLC  Hatim Husain,
SC09.04 Radiotherapy in China
P Comparison of Peri-Operative Outcomes after Robotic-Assisted Video- Thoracoscopic Lobectomies versus Segmentectomies  Maria Echavarria, Anna.
Plasma ctDNA Analysis for Detection of the EGFR T790M Mutation in Patients with Advanced Non–Small Cell Lung Cancer  Suzanne Jenkins, DPhil, James C-H.
MA12.06 Tumor Spread through Air Spaces (STAS) in Lung Squamous Cell Cancer is an Independent Risk Factor: A Competing Risk Analysis  Shaohua Lu, Takashi.
P3.02b-029 Primary Double EGFR Mutations T790M and Mutation in Exon 19 or 21 - Prevalence and Treatment Results in Slovakian NSCLC Patients  Peter Berzinec,
P3.02b-016 An Exploration Study of Mechanisms Underlying Primary Resistance to EGFR-TKIs in Patients Harboring TKI-Sensitive EGFR Mutations  Ee Ke, Zhihong.
IA05.01 Lung Cancer Cases Journal of Thoracic Oncology
P The Effect of Two Interventions on Attainment of Surgical Quality Measures in Resected Non-Small Cell Lung Cancer (NSCLC)  Nicholas Faris, Meredith.
P2.03b-023 Circulating Tumor DNA (ctDNA)-Based Genomic Profiling of Known Cancer Genes in Lung Squamous Cell Carcinoma (LUSC)  Vincent Lam, Hai Tran,
MA13.01 Markerless Tumor Tracking during Lung Radiotherapy Using Intrafraction X- Ray Imaging  Chun-Chien (Andy) Shieh, Vincent Caillet, Michelle Dunbar,
P The Impact of IASLC 8th Edition Updates for T-Classification for Lung Cancer in a US Population-Based Surgical Resection Cohort  Matthew Smeltzer,
Journal of Thoracic Oncology  Volume 12, Issue 5, Pages (May 2017)
Erik Jakobsen, Maria Iachina, Karen Ege Olsen, Anders Green 
Clinicopathologic Features of Advanced Squamous NSCLC
Journal of Thoracic Oncology  Volume 13, Issue 2, Pages (February 2018)
MA17.03 Identifying Genomic Alteration and Inter-Tumor Heterogeneity of Multiple Primary Lung Cancers by Targeted NGS of Tumor Tissue and ctDNA  Kezhong.
PS01.59: CheckMate 370: A Master Protocol of Phase 1/2 Studies of Nivolumab as Maintenance or First-Line ± Standard-of-Care Therapies in Advanced NSCLC 
P3.02b-075 Addition of Bevacizumab for Malignant Pleural Effusion as the Manifestation of Acquired EGFR-TKI Resistance in NSCLC Patients  Tao Jiang, Shengxiang.
A Hole in the Heart Journal of Thoracic Oncology
Journal of Thoracic Oncology  Volume 11, Issue 2, Pages (February 2016)
P3.02b-062 Safety of Necitumumab and Abemaciclib Combination Therapy in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)  Benjamin Besse, Johan.
Journal of Thoracic Oncology  Volume 12, Issue 7, Pages (July 2017)
Journal of Thoracic Oncology  Volume 12, Issue 8, Pages (August 2017)
ED11.01 Systemic Therapy for Advanced Oncogene-Driven NSCLC
MA04.02 Neratinib ± Temsirolimus in HER2-Mutant Lung Cancers: An International, Randomized Phase II Study  Leena Gandhi, Benjamin Besse, Julien Mazieres,
P3.02b-061 A Phase II Study of Nab-Paclitaxel (Nab-P) in Patients with Advanced Non- Small Cell Lung Cancer (NSCLC) with EGFR Mutations  Christina Baik,
Mitotic Inhibitors Journal of Thoracic Oncology
JCSE01.16 Positive Correlation Between Whole Genomic Copy Number Variant Scoring and the Grading System in Lung Non-Mucinous Invasive Adenocarcinoma 
Journal of Thoracic Oncology  Volume 11, Issue 10, Pages (October 2016)
A Primer on Health Economic Evaluations in Thoracic Oncology
Journal of Thoracic Oncology  Volume 12, Issue 10, Pages (October 2017)
P Comparison of Pulmonary Function after Robotic-Assisted Video- Thoracoscopic Lobectomies vs Segmentectomies  Maria Echavarria, Anna Cheng, Frank.
Journal of Thoracic Oncology  Volume 11, Issue 5, Pages (May 2016)
P3.02b-017 Sequence of EGFR-TKI Therapy and BIM Deletion Polymorphism Affect the Outcome of Treatment in EGFR Positive NSCLC  Chanchai Charonpongsuntorn,
P3.02b-052 Afatinib with or without Cetuximab for First-Line Treatment of EGFR-Mutant NSCLC: Interim Safety Results of SWOG S1403  Sarah Goldberg, James.
A2-06: Survival differences for non-Bronchioloalveolar Carcinoma (BAC) non-small-cell lung cancer (NSCLC) cases with ipsilateral intrapulmonary metastasis.
M. Kusumoto  Journal of Thoracic Oncology 
OA07.06 In Early-Stage Lung Adenocarcinomas, Survival by Tumor Size (T) is Further Stratified by Tumor Spread through Air Spaces  Takashi Eguchi, Koji.
Highly Sensitive Detection of EGFR T790M Mutation in Pre-TKI Specimens of EGFR- Mutated NSCLC: In Cis, In Trans, or a Different Clone?  Alvaro Leone, BSc.D 
MA12.05 Can Tumor Spread through Air Spaces (STAS) in Lung Adenocarcinomas Be Predicted Pre- and Intraoperatively?  Koji Kameda, Shaohua Lu, Takashi Eguchi,
Journal of Thoracic Oncology  Volume 13, Issue 3, Pages (March 2018)
P Implications of 8th Edition TNM Proposal: Invasive vs
OA Video-Assisted Thoracoscopic Surgery vs
PUB001 Advanced NSCLC Patients at the Extremes of Age in the Era of EGFR-TKIs  Yu-Mu Chen, Chien-Hao Lai, Huang-Chih Chang, Tung-Ying Chao, Chia-Cheng.
P Combined Molecular and Radiological Evaluation Unveils Three Subtypes of Disease Progression to a Third Generation EGFR TKI  Y. Zhang, Q. Zhou,
Journal of Thoracic Oncology  Volume 13, Issue 6, Pages (June 2018)
PS01.07 The Clinical Necessity of Extended Thymectomy for Thymic Squamous Cell Carcinomas Revealed by Exome Sequencing  J. Jiang, Y. Zhang, C. Jin, J.
Journal of Thoracic Oncology 
Current and Emergent Therapy Options for Advanced Squamous Cell Lung Cancer  Mark A. Socinski, MD, Coleman Obasaju, MD, PhD, David Gandara, MD, Fred R.
IASLC 6th Latin American Conference on Lung Cancer
PS01.37: Comparison Between Sanger Sequencing and ARMS qPCR Method for EGFR Gene Mutation Detection of Non–Small Cell Lung Cancer  Jiexia Zhang, Xiaoshun.
P1. 02: Lung Cancer - A Previously Years Survival Study
Clinicopathologic Features of NSCLC Diagnosed During Pregnancy or the Peripartum Period in the Era of Molecular Genotyping  Ibiayi Dagogo-Jack, MD, Justin.
Mark A. Socinski, MD  Journal of Thoracic Oncology 
MA01.03 The Non-Invasive LuCED® Test for Detection of Early Stage Lung Cancer  Michael Meyer, Timothy Bell, Daniel Sussman, David Wilbur, Chris Presley,
Y. Lou, R. Manochakian, J. Cochuyt, D. Hodge, S. Ailawadhi 
Robert Comis, MD, The Passing of a “Lung Man”
ED04.01 Surgery in Bronchopulmonary Typical and Atypical Carcinoids
Presentation transcript:

MA08.01 A Highly Sensitive Next-Generation Sequencing Platform for Detection of NSCLC EGFR T790M Mutation in Urine and Plasma  Heather Wakelee, Vlada Melnikova, Chris Karlovich, Shirish Gadgeel, Karen Reckamp, Jonathan W. Goldman, D. Ross Camidge, Maurice Pérol, Sai-Hong Ou, Stephen Liu, Helena Yu, Mark Socinski, Tarek Mekhail, Benjamin Solomon, Ronald Natale, Gregory Otterson, Vassiliki Papadimitrakopoulou, Jean-Charles Soria, Corey Langer, Joel Neal, Darrin Despain, Sergey Yurasov, Jason Litten, Mitch Raponi, Mark Erlander, Lecia Sequist  Journal of Thoracic Oncology  Volume 12, Issue 1, Pages S384-S385 (January 2017) DOI: 10.1016/j.jtho.2016.11.434 Copyright © 2016 Terms and Conditions

Journal of Thoracic Oncology 2017 12, S384-S385DOI: (10. 1016/j. jtho Copyright © 2016 Terms and Conditions